Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP179213.RAwg-reLD2l1LZSQd3GOqtN11Nt7PASFaIPP7zgcxg0nw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP179213.RAwg-reLD2l1LZSQd3GOqtN11Nt7PASFaIPP7zgcxg0nw130_assertion type Assertion NP179213.RAwg-reLD2l1LZSQd3GOqtN11Nt7PASFaIPP7zgcxg0nw130_head.
- NP179213.RAwg-reLD2l1LZSQd3GOqtN11Nt7PASFaIPP7zgcxg0nw130_assertion description "[When the expressions of SIK3 and CA125 were compared in cancer tissues, immunohistochemical (IHC) studies indicated that cytoplasm-localized SIK3 was highly expressed in 55% of the ovarian cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP179213.RAwg-reLD2l1LZSQd3GOqtN11Nt7PASFaIPP7zgcxg0nw130_provenance.
- NP179213.RAwg-reLD2l1LZSQd3GOqtN11Nt7PASFaIPP7zgcxg0nw130_assertion evidence source_evidence_literature NP179213.RAwg-reLD2l1LZSQd3GOqtN11Nt7PASFaIPP7zgcxg0nw130_provenance.
- NP179213.RAwg-reLD2l1LZSQd3GOqtN11Nt7PASFaIPP7zgcxg0nw130_assertion SIO_000772 21399663 NP179213.RAwg-reLD2l1LZSQd3GOqtN11Nt7PASFaIPP7zgcxg0nw130_provenance.
- NP179213.RAwg-reLD2l1LZSQd3GOqtN11Nt7PASFaIPP7zgcxg0nw130_assertion wasDerivedFrom befree-20140225 NP179213.RAwg-reLD2l1LZSQd3GOqtN11Nt7PASFaIPP7zgcxg0nw130_provenance.
- NP179213.RAwg-reLD2l1LZSQd3GOqtN11Nt7PASFaIPP7zgcxg0nw130_assertion wasGeneratedBy ECO_0000203 NP179213.RAwg-reLD2l1LZSQd3GOqtN11Nt7PASFaIPP7zgcxg0nw130_provenance.